Message ID:  2055 Public Message Priority:  Advisory

Idaho Health Alert Network
Health Message Details

From:   Health District 7 - Eastern Idaho Public Health (PHD7)
Sent:   4/25/2022 12:22:33 PM
To:   District Director (PHD7), Epidemiologist (PHD7), Family Health Director (PHD7), Community Health Director (PHD7), Environmental Health Director (PHD7), BT Program Manager (PHD7), Immunization Program Coordinator (PHD7), Food Program Coordinator (PHD7), Public Information Officer (PHD7), Primary Care Provider (PHD7), Specialist, Non-Primary Care (PHD7), Nurse (PHD7), Pharmacy (PHD7), Cardiology (PHD7), Contract Physcians / Pharmacists (PHD7), Dermatology (PHD7), Emergency Medicine (PHD7), Family Medicine (PHD7), Gastroenterology (PHD7), General Practice (PHD7), Internal Medicine (PHD7), Licensed Practical Nurse (PHD7), Neurology (PHD7), Nurse Practitioner (PHD7), OB / GYN (PHD7), Oncology (PHD7), Ophthalmology (PHD7), Orthopedics (PHD7), Other (PHD7), Pathology (PHD7), Pediatrics (PHD7), Physician Assistant, Primary Care (PHD7), Podiatry (PHD7), Psychiatry / Psychology (PHD7), Public Health Nurse (PHD7), Pulmonary (PHD7), Radiology (PHD7), Registered Nurse (PHD7), Satellite Offices (PHD7), Surgeons (PHD7), Urology (PHD7), Infection Control Practitioners (PHD7), Infectious Disease Physician (PHD7), Infection Preventionist (PHD7)
Subject:   Eastern Idaho Public Health to Begin Offering Evusheld

PHIN Specific Data
Severity: Moderate Delivery Time: 15 Minutes
PHIN Status: Actual Message Type: Alert
Sensitivity: Non Sensitive Acknowledgement: No


April 25, 2022

Eastern Idaho Public Health to Begin Offering Evusheld
This Preventative Antibody Therapy is FDA-EUA Authorized

Eastern Idaho Public Health (EIPH) is pleased to announce that we have started offering Evusheld at all our locations.

Evusheld is an FDA-EUA authorized preventative monoclonal antibody therapy for individuals who are immunocompromised; or individuals who are not effectively protected by the COVID-19 vaccine or unable to receive the COVID-19 vaccine. Patients must also not be currently infected with COVID-19, have not recently been exposed to an infected individual, and meet the additional guidelines provided under the FDA’s Emergency Use Authorization.

Per EIPH standing orders, any individual who has a history of cardiovascular disease and/or who is pregnant, will need an order from their Primary Care Provider to receive Evusheld at our office.

Patients can contact our scheduling line at 208-533-3223 or 855-533-3160 to schedule an appointment starting April 25, 2022.
The following locations will offer Evusheld:

Bonneville County:             Jefferson County:                 Madison County: 
1250 Hollipark Drive          380 Community Lane           314 N 3rd E
Idaho Falls, ID 83401         Rigby, ID 83442                   Rexburg, ID 83440

Fremont County:                 Teton County:                          Clark County:
45 S 2nd W                          820 Valley Centre Dr              332 W Main
St Anthony, ID 83445         Driggs, ID 83422                    Dubois, ID 83423

Custer County:                     Lemhi County:  
610 Clinic Road Ste A         801 Monroe
Challis, ID 83226                 Salmon, ID 83467 


Thank you,
Esmeralda Quintero, BSN RN
Eastern Idaho Public Health
COVID Vaccine Manager

The following files(s) are attached to this health message:
To access the attachments online, go to